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Purification of Human Epidermal Calmodulin 
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Department of Dermatology, The Oregon Health Sciences University, Portland, Oregon, U.S.A . 
Human epidermal calmodulin was purified by pheno-
thiazine-Sepharose affinity chromatography. The pro-
tein stimulated activator-deficient phosphodiesterase 
and was identified to be calmodulin by radioimmunoas-
say. Epidermal calmodulin demonstrated aM,. of 17,000 
on gel permeation chromatography and migrated on 
sodium dodecyl sulfate-urea-polyacrylamide gel electro-
phoresis as a single band at the same location as rat 
testes calmodulin. The exact role of calmodulin in the 
epidermis remains to be d efined. 
Calmodulin is a heat stable, ubiquitous, 17,000 dalton protein 
that activates many calcium-dependent enzymes including 
cyclic nucleotide phosphodiesterase [1], adenylate cyclase [2, 
3], ATPase [ 4], and phosphorylase kinase [5]. 
Murray and Rogers [6] in 1978 reported the partial purifica-
tion from mouse epidermis of a protein that stimulated modu-
lator-depleted cyclic AMP phosphodiesterase. Recently, Iizuka 
et al [7] reported the presence of calmodulin in pig skin epider-
mis. The addition of boiled skin extract to a crude extract of 
epidermal phosphodiesterase had a minimal effect on the en-
zyme activity. They concluded t hat calmodulin was present in 
significant amounts in the epidermis, but that its main role 
probably is not the regulation of phosphodiesterase. 
We report the first purification of calmodulin from epidermis. 
Its role in keratinization is cunently under investigation. 
MATERIALS AND METHODS 
Assays 
Calmodulin activity was assayed using the method of S ugden [8]. 
Activator-deficient bovine hear t phosphodiesterase (P-0520) and cyclic 
["H]AMP were obtained from Sigma (St. Louis, Missouri) . One uni t of 
calmodulin was defined as the ability to stimulate 0.016 units of P -0520 
(pH 7.5) to 50% maximal activi ty of the enzyme when saturated with 
activator and in the presence of 10 J.I.M calcium ion. 
Radio immunoassay for calmodulin was performed using a calmodu-
lin e""l) radioimmunoassay kit (New E ngland Nuclear , Boston, M as-
sachusetts). This kit is a competitive inhibi tion type system which 
utilizes 1251-labeled bovine brain calmodulin as the tracer and a highly 
specific affinity-purified sheep ant icalmod ulin as the binder. Separation 
of the antigen-antibody complexes from free calmodulin is achieved by 
using an acce lerated second ant ibody system. After centrifugation, the 
supernatant is discarded and radioactivi ty in the pe llet is measured by 
gamma coun ting. Calmodulin standard concent rate supplied wi th the 
ki t is used to obtain a s tandard curve ranging from 0.31-20 ng. E pider-
mal samples containing calmodulin were dilu ted to fa ll within this 
range of standards. This kit was used to identify calmodulin and a lso to 
determine its concentration. 
Human. Epidermal Calmodulin. Purification 
Human epidermis fro m 10 below-th e-knee amputations was obtained 
by heat separation at 56°C. The epithelium was subsequently snap-
frozen in liquid nitrogen, pulverized, and homogenized in a Polytron 
(Brinkman Instruments, Westburg, New York) in cold 0.025 M ammo-
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nium acetate/0.001 M EDTA, pH 8.5. The soluble extract, following 
centrifugation at 40,000 g fo r 45 min in a Sorvall RC2B refrigerated 
centrifuge, was partially purified by Amicon ultrafllt ration (Amicon 
Corp ., Lexington, Massachusetts) using a PM-50 membrane. The ex-
tract was then concentrated to 5 ml with a YM-10 membrane and 
dialyzed exhaustively in a buffer contain ing 0.5 mM CaCb, 500 m M 
NaCl, and 10 mM Hepes, pH 7.0. Affi-Gel phenothiazine (Bio-Rad, 
Richmond, Califo rnia) was equilibrated in the sam e buffe r and pomed 
in to a 0.5 em X 8.0 em column. The extract was then applied at 15 ml/ 
h, and the column was washed with the buffer unt il Az"o was 0 . A280 
was monitored in a Zeiss PMQ II spectrophotometer with a 1-cm light 
path. Calmodu lin was then elu ted in 2-ml fractions with a buffer 
containing 5 mM EGTA and 10 mM Tris, pH 8.0. 
Molecular W eight Determinations 
The M ,. of calmodulin was determined by ACA-54 Ultrage l (LKB 
Western Instruments, Pleasant Hills, California) column chromatog-
raphy and by 1% sodium dodecyl sulfa te (SDS)-6 M urea-15% slab 
polyacrylamide gel electrophoresis (Hoefer Scientific Instruments, San 
Francisco, California) [9]. P rotein markers on column chromatography 
included blue dextran (2,000,000 daltons), bovine serum albumin (67,000 
daltons), carboxypept idase (35,000 daltons), egg white trypsin inhibitor 
(28,000 daltons), and cytochrome C (13,500 daltons). F low rate was 6 
ml/h and 0.5-ml fractions were collected. On SDS-urea-slab polyacryl-
amide gel elec trophoresis, commercia lly purchased rat testes calmod-
ulin (Caabco, Inc., Houston, Texas) was used as a marker. Twenty 
micrograms of each sample was heated to 97°C for 3 min in 1% SDS 
prior to application. 
Other Determinations 
Coomassie Brilliant blue G-250 was obtained from Spectrum and 
used exclusively fo r protein determinations [10]. 
RESULTS 
One gram of soluble protein was obtained from the heat-
separated epidermis. This crude extract demonstrated a cal-
modulin sp act of 0.5 units/mg. Amicon PM-50 ultrafiltration 
removed a majority of the higher M,. proteins above 50,000, 
increasing the sp act 10-fold. E ssentially all of the epidermal 
calmodulin was bound to the phenothiazine-Sepharose column 
as evidenced by the absence of stimulation of phosphodiesterase 
activity or by detection of calmodulin by radioimmunoassay in 
fraction 2, shown in Fig 1. With the chelation of calcium by 
EGTA, the calmodulin lost its affinity for phenothiazine, and 
calmodulin was eluted in fraction 13. Thf purified protein in 
the standard assay stimulated phosphodiesterase activity to a 
similar extent as did the commercially purchased rat testes 
calmodulin at varying concentrations of each protein. 
Twenty-five micrograms of protein was pw-ifled and demon-
strated asp act of 5,000 units/mg. M ,. characterization by ACA-
54 gel permeation column chromatography yielded a single 
symmetrical peak of M,. 17,000 (Fig 2), and by SDS-urea-gel 
electrophoresis, epidermal calmodulin migrated as a single band 
in a pattern similar to rat testes calmodulin (Fig 3). Impurities 
were evident in the commercially pmchased preparations at 
high er M ,s. 
Finally, the purified epidermal calmodulin was identified to 
be actual calmodulin by radioimmunoassay. Spectrophotomet-
ric measurem ent of calmodulin concentration was in accordance 
with protein concentrat ion determined by radioimmunoassay. 
The final yield of the human epidermal calmodulin was 20%, as 
shown in T able I. 
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FIG 1. P urification of human epidermal ca lmodulin by phenothia-
zine-Sepharose affinity chwmatography. Flow rate was 15 ml/h a nd 2-
m! fractions were collected. Fraction 13 contammg calmodulin was 
elu ted with the addition of 5 mM EGTA in 10 mM T ris buffer, pH 8.0. 
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FIG 2. M,. determina tion of purified epidermal calmodu lin by ACA-
54 gel permeation chromatography. Flow rate was 6 ml/h and 0.5-ml 
fractions were collected. Calmodulin elu tes between cytochrome C and 
egg white trypsin inhibi tion. 
DISCUSSION 
The presence of calmodulin in the epidermis was suggested 
by Murray and Rogers [6] and by Iizuka et al [7] working with 
crude preparations. This report outlines a method for its puri-
fication from epidermis by using the technique of affinity chro-
matography. 
Incubation of skin at 56°C allows the efficient separation of 
the epidermis from t he underlying dermis by dissociating the 
basal lamina as shown previously [11]. Epidermal calmodulin 
is obtained without contamination of calmodulin from the 
dermis, which contains blood vessels, muscle, and nerves. 
As can be seen in Table I, this purification procedme pro-
duces a 10,000-fold increase in purity over crude extract. The 
most important step is phenothiazine-Sepharose chromatogra-
phy. A 1000-fold increase in sp act is achieved, a nd this dem-
A B 
FIG 3. Comparison of M,. between (A) 20 p.g rat testes calmodulin 
and (B) 20 jl.g human epidermal calmodu lin on 15% urea-SDS-6 M urea 
polyacrylamide gel electrophoresis. 
TABLE I. Purification of human epidermal calmodulin 
Pro- Activity Purifica- Yield Purification s tep tein U/ mg 
(mg) (U) tion (%) 
Crude homogenate 1,000 500.0 0.5 1.0 100 
PM-50 ultraftltra tion 60 300.0 5.0 10.0 60 
Phenothiazine-Sepha- 0.025 125.0 5,000.0 10,000.0 25 
rose chromatography 
ACA-54 Ult ragel chro- 0.020 100.0 5,000.0 10,000.0 20 
matography 
onstrates phenothiazine's remarkable specificity for calmodulin . 
In fact, we expected some impurit ies to be present on gel 
fil tration chromatography of SDS-gel electrophoresis, but none 
was observed. Murray and Rogers [6) estimated calmodulin to 
compromise 1% of the soluble protein of mouse epidermis. From 
our data it is approximately 0.0025%. 
This pmified protein appea1·s to be calmodulin for the follow-
ing reasons: (1) its ability to stimulate phosphodiesterase to a 
similar degree as t:at testes calmodulin and at simila r concen-
trations; (2) its calcium-dependent affinity for phenothiazine; (3) its M ,. of approximately 17,000 by SDS electrophoresis and 
gel permeation chromatography; and finally, (4) its identity by 
radioimmunoassay as calmodulin. It was important to correlate 
protein concen tration by spectrophotometric means and by 
radioimmunoassay. This showed that the protein isolated was 
entirely calmodulin and not a different protein contaminated 
with a small amount of calmodulin . Epidermal calmodulin 
appears similar to calmodulin from other tissues. T his is ex-
pected since it is a highly conserved molecule [12,13]. 
We would like to thank Sai Chan for assisting with the calmodulin 
r:;dioimmunoassay. 
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Plasma Androgens in Women with Acne Vulgaris 
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We have studied a group of young adult women of 
mean age 23.8 ± 6.5 (SD) years with only acne (A, n = 
46), only hirs utism (H, n = 10), and acne plus hirsutism 
(A+H, n = 19) who sought dermatologic care. We meas-
ured the androgens, total and free testosterone (T), free 
17 ,8-hydroxysteroids (17 -,B), dehydroepiandrosterone 
sulfate (DS), and the androgen precursors 17a-hydroxy-
pregnenolone (17 -Pre g) and 17 a-hydroxyprogesterone 
(17-Prog), as well as testosterone-estrogen binding glob-
ulin in all patients. Plasma hormone levels of the patients 
were compared to those of 23 controls of mean age 25.6 
± 6.6 years who had neither acne nor hirsutism. Mean 
levels of all hormones measured, except 17-Preg, were 
elevated in the women with acne. Fifty-two percent of 
Group A, 60% of Group H, and 63% of Group A+H pa-
tients had at least one abnormal hormone level. The 
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most frequently elevated plasma androgens in all the 
women with acne were: free T 25%, free 17-,B 23%, and 
DS 19%. Total T was high in only 12%. Elevations of 
plasma androgens were present in some women who did 
not have hirsutism or irregular menses. Identification of 
endocrine abnormalities in women with acne may poten-
tially offer an opportunity for hormonal therapy. 
Acne vulgaris is a disorder of sebaceous follicles. It is well 
known that androgens stimulate the pilosebaceous unit; .how-
ever, the clinical role of circulating plasma androgens in the 
pathogenesis of acne has seldom been documented. With the 
advent of new techniques for m easuring free plasma a ndrogens, 
elevations of androgens have been found in a large percentage 
of hirs ute women [1]. Until recently [2,3], most h yperandroge-
nemia in women with acne h as been detected during evaluation 
of hirsutism or menstrual disorders. In this study we have 
measured plasma androgens and their precursors in 75 women 
of mea n age 23.8 ± 6.5 (SD) years who came to a dermatology 
clinic for acne and/or hirsutism. We m easured the androgens, 
total testosterone (total T), free testosterone (free T), free 17,8-
hydroxysteroids (free 17 -,B), dehyru·oepiandrosterone sulfate 
(DS) , a nd the androgen precursors 17a-hydroxypregnenolone 
(17-Preg) and 17a -hyru·oxyprogesterone (17-Prog), as well as 
testosterone-estrogen binding globulin (TEBG) , and compared 
levels in the patients to those in control, age-matched women 
who ha d no significant acne or hirsutism. We have found a 
significant incidence ofhyperandrogenemia in women with acne 
vulgaris. 
MATERIALS AND METHODS 
Patients 
Seventy- five women of mean age 23.8 ± 6.5 (SD) years came to the 
Dermatology Clinic at the Yale New Haven Hospital Medical Center 
